Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India

Back Stocks profile

Stock analysis tool for investors

Zydus Wellness Ltd.

NSE: ZYDUSWELL | BSE:531335

₹2118.25 20.35 (0.97%) 1D

FMCG

Buy Sell
View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2072.00

Today’s High

2135.00

52W low

1425.00

52W High

2135.00

Open Price

2081.00

Prev. Close

1881.3000

Volume

54557.00

Value

115565365.25

Fundamentals

Market Cap

13478.90

Price to Earnings

50.50

Price to Book Value

2.50

Dividend Yield

0.20

PE to Growth

-3.60

Op Revenue TTM

2327.80

Net Profit TTM

266.90

Cash From Operating Activity

246.40

Return on Equity %

4.98

EMA & SMA

Bullish Moving Averages

16

Bearish Moving Averages

0

5Day EMA

2030.1

10Day EMA

1962.5

12Day EMA

1946.5

20Day EMA

1903.1

26Day EMA

1879.2

50Day EMA

1809.2

100Day EMA

1729.6

200Day EMA

1662.1

5Day SMA

2014.4

10Day SMA

1917.1

20Day SMA

1895.1

30Day SMA

1854

50Day SMA

1792.7

100Day SMA

1679

150Day SMA

1655.4

200Day SMA

1630.4

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

05 Jul, 2024

50.9

Week

38.6

Month

46.9

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2108.42

PIVOT

First Resistance

2144.83

Second Resistance

2171.42

Third Resistance

2207.83

First Support

2081.83

Second Support

2045.42

Third Support

2018.83

Relative Strength Index

75.22

Money Flow Index

81.91

MACD

67.3

MACD Signal

42.72

Average True Range

71.2

Average Directional Index

32.38

Rate of Change (21)

11.76

Rate of Change (125)

25.37

Commodity Channel Index

234

Williams %R

-4.6

BETA

1 Month

2.03

3 Month

0.42

1 Year

0.36

3 Year

0.12

PRICE CHANGE ANALYSIS

↑ 18.6%

1 Week

Low

High

1791

2135

↑ 11.76%

1 Month

Low

High

1771

2135

↑ 34.77%

3 Months

Low

High

1550.15

2135

↑ 25.23%

6 Months

Low

High

1440.15

2135

↑ 43.18%

1 Year

Low

High

1425.05

2135

Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 67.80 68.40 62.40 64.20 62.32 67.06 70.11 65.51 63.98 74.56 56.31
Operating Expenses Qtr 55.60 53.00 50.30 52.90 50.68 51.37 54.73 56.39 56.79 60.76 57.14
Operating Profit Qtr 7.50 10.80 7.50 7.20 8.06 12.35 12.49 5.41 3.64 10.10 -4.76
EBIDT Qtr Cr 12.20 15.40 12.10 11.30 11.64 15.69 15.38 9.12 7.19 13.80 -0.83
Depreciation Qtr 0.90 0.90 0.90 0.90 1.00 0.74 1.06 0.72 0.77 0.70 0.69
Net Profit Qtr 7.40 10.30 7.80 8.20 28.66 15.03 14.78 7.95 13.41 12.56 -2.02
Basic EPS Qtr 1.16 1.62 1.23 1.29 4.50 2.36 2.32 1.25 2.11 1.97 -0.32
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 262.80 265.00 231.65 180.63 262.91
Operating Expenses Annual Cr 211.80 213.17 221.57 163.55 174.29
Operating Profit Annual 33.00 38.31 -5.32 -49.72 -20.86
Operating Profit Margin Annual % 12.56 14.46 -2.30 -27.53 -7.93
Total Expenses Annual Cr 218.00 217.83 226.43 241.70 317.53
EBIDT Annual Cr 51.00 51.83 10.08 17.08 88.62
EBIDT Annual margin % 19.41 19.56 4.35 9.46 33.71
Depreciation 3.60 3.52 2.84 3.49 2.95
PAT Before ExtraOrdinary Items Annual Cr 33.70 66.42 12.70 -182.14 -40.73
Net Profit Annual 33.70 66.42 12.70 -182.14 -40.73
Basic EPS Annual 5.30 10.44 2.00 -29.99 -7.06
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 4035.90 4034.28 4000.18 4019.29 3214.70
Minority Interest Liability Annual Cr - - - - -
Total Non Current Liabilities Annual Cr 4.90 4.03 2.89 3.61 1503.03
Total Current Liabilities Annual Cr 75.00 28.52 87.43 93.55 85.03
Total Capital Plus Liabilities Annual Cr 4115.80 4066.83 4090.50 4116.45 4802.76
Fixed Assets Annual 58.10 55.04 46.77 44.92 44.19
Total Non Current Assets Annual 3984.00 3896.78 3968.72 3984.21 4715.12
Total Current Assets Annual 131.80 170.05 121.78 132.24 87.64
Total Assets Annual 4115.80 4066.83 4090.50 4116.45 4802.76
Contingent Liabilities plus Commitments Annual Cr - 11.22 11.23 7.67 7.50
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 26.00 36.67 -16.27 -51.95 -19.67
Cash from Investing Activity Annual -47.20 0.66 39.33 816.14 266.58
Cash from Financing Annual Activity 15.40 -79.33 -37.69 -709.99 -260.09
Net Cash Flow Annual - -42.00 -14.63 54.20 -13.18
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 634.58 634.02 628.66 631.66 557.53
ROE Annual % 0.83 1.64 0.31 -4.53 -1.26
ROCE Annual % 1.17 1.19 0.18 0.33 1.81
Total Debt to Total Equity Annual 0.01 0.00 0.01 0.01 0.47
EBDIT Annual Margin % 20.83 20.60 4.66 15.00 57.75
Indicator Mar 2024 Dec 2023 Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021 Sep 2021 Graph
Total Qtr Revenue cr 786.60 406.60 444.00 704.50 713.70 416.42 430.82 698.71 641.74 390.78 387.01
Operating Expenses Qtr 620.40 390.50 423.10 585.60 568.40 387.39 413.21 548.64 498.28 355.80 353.11
Operating Profit Qtr 162.20 12.70 16.80 116.50 144.58 28.19 16.26 148.12 141.50 32.29 30.54
EBIDT Qtr Cr 166.20 16.10 20.90 104.70 138.16 29.03 17.61 147.16 143.46 34.98 33.90
Depreciation Qtr 5.70 6.10 5.80 6.20 6.67 5.88 6.43 6.04 6.08 5.84 6.11
Net Profit Qtr 150.30 0.30 5.90 110.40 145.33 19.56 8.47 137.01 133.30 23.30 21.47
Basic EPS Qtr 23.62 0.05 0.93 17.35 22.84 3.07 1.33 21.53 20.95 3.66 3.37
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total Revenue Annual 2341.70 2259.65 2019.50 1875.61 1777.53
Operating Expenses Annual Cr 2019.60 1917.64 1664.35 1522.31 1445.76
Operating Profit Annual 308.20 337.15 344.75 344.36 321.06
Operating Profit Margin Annual % 13.16 14.92 17.07 18.36 18.06
Total Expenses Annual Cr 2067.40 1958.74 1713.48 1631.27 1612.06
EBIDT Annual Cr 322.10 342.01 355.15 353.30 331.77
EBIDT Annual margin % 13.75 15.14 17.59 18.84 18.66
Depreciation 23.80 25.02 23.62 25.16 26.39
PAT Before ExtraOrdinary Items Annual Cr 266.90 310.37 308.87 118.73 141.72
Net Profit Annual 266.90 310.37 308.87 118.73 141.72
Basic EPS Annual 44.18 48.78 48.54 19.55 24.58
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Total ShareHolders Funds Annual 5357.50 5122.65 4844.03 4567.79 3460.66
Minority Interest Liability Annual Cr 0.00 0.00 0.00 0.00 0.00
Total Non Current Liabilities Annual Cr 21.50 18.00 81.34 327.72 1513.86
Total Current Liabilities Annual Cr 769.40 692.40 766.81 770.92 615.16
Total Capital Plus Liabilities Annual Cr 6148.40 5833.05 5692.18 5666.43 5589.68
Fixed Assets Annual 797.20 825.32 801.84 751.12 757.03
Total Non Current Assets Annual 4898.40 4924.57 4878.48 4819.54 4813.89
Total Current Assets Annual 1250.00 908.48 813.70 846.89 775.79
Total Assets Annual 6148.40 5833.05 5692.18 5666.43 5589.68
Contingent Liabilities plus Commitments Annual Cr - 362.70 336.65 327.40 295.38
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Cash from Operating Activity Annual 246.40 91.71 236.85 286.51 259.25
Cash from Investing Activity Annual -19.30 -84.84 -58.93 -10.41 -17.12
Cash from Financing Annual Activity -25.70 -138.49 -233.82 -216.21 -259.69
Net Cash Flow Annual - -131.62 -55.90 59.89 -17.56
Indicator Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Graph
Book Value Per Share Annual 842.37 805.07 761.28 717.87 600.18
ROE Annual % 4.98 6.05 6.37 2.59 4.09
ROCE Annual % 5.54 6.16 6.73 6.70 6.13
Total Debt to Total Equity Annual 0.06 0.06 0.08 0.12 0.44
EBDIT Annual Margin % 13.83 15.16 17.67 18.92 18.77
Name Holding Percent Holding Id Pledged % Locked %
Sbi Small Cap Fund 2.2 74202336 - -
Icici Prudential Value Discovery Fund 2.02 74202337 - -
Name Holding Percent Holding Id Pledged % Locked %
Zydus Lifesciences Limited 57.59 74202329 0 0
Zydus Family Trust(Trustee:Mr. Pankaj R. Patel,Smt. Pritiben P. Patel, Dr. Sharvil P. Patel) 12.01 74202330 0 0
Name Holding Percent Holding Id
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund 3.49 74202335
Sbi Small Cap Fund 2.2 74202336
Icici Prudential Value Discovery Fund 2.02 74202337
Threpsi Care Llp 10.12 74202340
Name Holding Percent Holding Id
Ex-Date Dividend Amount Dividend Type Record Date Instrument Type
Jul 21, 2023 5 FINAL Jul 21, 2023 Equity Share
Jul 14, 2022 5 FINAL Jul 15, 2022 Equity Share
Jul 14, 2021 5 FINAL - Equity Share
Mar 19, 2020 5 INTERIM Mar 21, 2020 Equity Share
Feb 27, 2020 - INTERIM Feb 28, 2020 Equity Share
Jul 17, 2019 5 FINAL - Equity Share
Jul 18, 2018 8 FINAL - Equity Share
Mar 09, 2017 6.5 INTERIM Mar 10, 2017 Equity Share
Mar 16, 2016 6.5 INTERIM Mar 17, 2016 Equity Share
Jul 16, 2015 6 FINAL - Equity Share
Jul 03, 2014 6 FINAL - Equity Share
May 22, 2013 6 INTERIM May 23, 2013 Equity Share
Jul 18, 2012 5 FINAL - Equity Share
Jun 22, 2011 4 FINAL - Equity Share
Jul 08, 2010 3 FINAL - Equity Share
Jul 16, 2009 1.5 FINAL - Equity Share
Jul 03, 2008 1 FINAL - Equity Share
Jul 12, 2007 1 FINAL - Equity Share
Sep 21, 2006 1 FINAL - Equity Share
Sep 21, 2004 0.8 FINAL - Equity Share
Sep 18, 2003 0.6 FINAL - Equity Share
Sep 18, 2002 - FINAL - Equity Share
Ex-Date Split Ratio Record Date
Ex-Date Purpose Notes
May 14, 2024 Audited Results & Final Dividend -
Feb 08, 2024 Quarterly Results -
Nov 06, 2023 Quarterly Results -
Aug 03, 2023 Quarterly Results -
May 17, 2023 Audited Results & Final Dividend -
Feb 02, 2023 Quarterly Results -
Nov 10, 2022 Quarterly Results -
Jul 29, 2022 Quarterly Results -
May 17, 2022 Audited Results & Final Dividend -
Feb 02, 2022 Quarterly Results -
Oct 28, 2021 Quarterly Results -
Jul 30, 2021 Quarterly Results -
May 10, 2021 Audited Results & Final Dividend -
Feb 01, 2021 Quarterly Results -
Nov 02, 2020 Quarterly Results -
Oct 07, 2020 General Purpose -
Aug 27, 2020 Preferential Issue of shares -
Jul 31, 2020 Quarterly Results -
Jun 02, 2020 Audited Results -
Mar 13, 2020 Interim Dividend -
Feb 15, 2020 Interim Dividend -
Feb 05, 2020 Quarterly Results -
Nov 13, 2019 Quarterly Results -
Jul 31, 2019 Quarterly Results -
May 28, 2019 Audited Results & Final Dividend -
Feb 06, 2019 Quarterly Results -
Dec 06, 2018 Preferential Issue of shares -
Nov 02, 2018 Quarterly Results -
Aug 03, 2018 Quarterly Results -
May 24, 2018 Audited Results & Dividend -
Feb 07, 2018 Quarterly Results -
Nov 13, 2017 Quarterly Results -
Aug 10, 2017 Quarterly Results -
May 27, 2017 Audited Results -
Mar 01, 2017 Interim Dividend -
Jan 30, 2017 Quarterly Results -
Oct 25, 2016 Quarterly Results -
Aug 02, 2016 Quarterly Results -
May 12, 2016 Audited Results -
Mar 04, 2016 Interim Dividend -
Feb 04, 2016 Quarterly Results -
Oct 21, 2015 Quarterly Results -
Jul 29, 2015 Quarterly Results -
May 14, 2015 Audited Results & Dividend Appointed Mr. Tarun Arora as an Additional Director & Chief Operating Officer of the Company.
Feb 09, 2015 Quarterly Results -
Nov 05, 2014 Quarterly Results -
Jul 14, 2014 Quarterly Results -
May 15, 2014 Audited Results & Dividend -
Feb 06, 2014 Quarterly Results -
Oct 30, 2013 Quarterly Results -
Aug 07, 2013 Quarterly Results -
May 13, 2013 Audited Results & Dividend -
Feb 07, 2013 Quarterly Results -
Nov 06, 2012 Quarterly Results -
Jul 27, 2012 Quarterly Results -
May 09, 2012 Audited Results & Dividend -
Feb 06, 2012 Quarterly Results -
Nov 09, 2011 Quarterly Results -
Jul 18, 2011 Quarterly Results -
May 05, 2011 Audited Results & Dividend -
Jan 17, 2011 Quarterly Results -
Oct 18, 2010 Quarterly Results -
Jul 16, 2010 Quarterly Results -
Apr 28, 2010 Audited Results & Dividend -
Jan 25, 2010 Quarterly Results -
Oct 14, 2009 Quarterly Results -
Jul 29, 2009 Quarterly Results -
Apr 27, 2009 Audited Results & Dividend -
Jan 23, 2009 Quarterly Results -
Jan 17, 2009 Allotment of equity shares To allot 3,34,96,989 Equity Shares of Rs 10/- each fully paid up ("New Equity Shares") to the shareholders of Cadila Healthcare Ltd., As per the Composite Scheme of Arrangement.
Oct 20, 2008 Quarterly Results -
Jul 30, 2008 Quarterly Results -
Jul 04, 2008 Composite Scheme of Arrangement To approve the "Composite Scheme of Arrangement between Cadila, Carnation & Zydus Hospitals & Medical Research Pvt Ltd", to effect restructuring of the Consumer Products Division of Cadila & Carnation
Apr 28, 2008 Audited Results -
Oct 26, 2007 Quarterly Results -
Jul 31, 2007 Quarterly Results -
Apr 25, 2007 Audited Results & Dividend -
Oct 30, 2006 Quarterly Results -
Jul 27, 2006 Accounts, Dividend & Qtr. Results Accounts for the year ended 31/03/06.
Apr 28, 2006 Quarterly Results -
Jan 30, 2006 Quarterly Results -
Oct 28, 2005 Quarterly Results -
Jul 29, 2005 Quarterly Results -
Jun 02, 2005 Re-issue of forfeited shares (Revised)
Apr 28, 2005 Quarterly Results -
Aug 20, 2004 Accounts & Dividend -
Jul 30, 2004 Quarterly Results -
Apr 30, 2004 Quarterly Results -
Jan 30, 2004 Quarterly Results -
Jul 28, 2003 Quarterly Results -
Apr 29, 2003 Quarterly Results -
Jan 30, 2003 Quarterly Results -
Apr 30, 2002 Quarterly Results -
Jan 31, 2002 Quarterly Results -
Oct 31, 2001 Quarterly Results -
Jul 31, 2001 Quarterly Results -
Apr 30, 2001 Quarterly Results -
Jul 31, 1999 Quarterly Results -
Jan 29, 1999 Quarterly Results -
Dec 30, 1997 Accounts. -
Ex-Date Bonus Ratio Record Date
Bigul
05 Jul 2024

ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Newspaper publication for 30th AGM
04 Jul 2024

Zydus Lifesciences Hits One-Month High As FDA Approves Its Hypertension Drug

 The stock rose as much as 4.53% during the day to Rs 1,144.90 apiece on the NSE.
Bigul
25 Jun 2024

ZYDUS WELLNESS LTD.-$ - 531335 - Closure of Trading Window

 Intimation for Trading Window closure
Bigul
25 Jun 2024

F&O Query: Should you sell Zydus Lifesciences call option?

 Only a decisive break of the base at 1,000 can turn the trend bearish
Bigul
19 Jun 2024

Nepal's drug regulator bans sale of Indian antibiotic over quality issues

 Zydus Lifesciences said the reports were 'misleading and erroneous'
14 Jun 2024

Zydus Lifesciences Gets Tentative Approval From US FDA For New Drug

 The Azilsartan Medoxomil and Chlorthalidone tablets are prescribed for the treatment of high blood pressure.
Bigul
11 Jun 2024

ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate under reg. 39(3) of the SEBI (LODR) Regulations, 2015
Bigul
07 Jun 2024

ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate under reg. 39(3) of the SEBI (LODR) Regulations, 2015
Bigul
04 Jun 2024

ZYDUS WELLNESS LTD.-$ - 531335 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Disclosure under SEBI (PIT) Regulations, 2015
Bigul
28 May 2024

ZYDUS WELLNESS LTD.-$ - 531335 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 Intimation of loss of share certificate under reg. 39(3) of the SEBI (LODR) Regulations, 2015
See all News

FAQs

The latest market price of Zydus Wellness Ltd. on NSE was Rs. 2118.25 as of today.

The opening share price of Zydus Wellness Ltd. was Rs. 2081.00 as of today.

The 52-week high share price of Zydus Wellness Ltd. was Rs. 2135.00.

The 52 week low share price of Zydus Wellness Ltd. was Rs. 1425.00.

Please find Corporate actions section for more details.

The PE ratio of Zydus Wellness Ltd. is -3.60. Please refer to the Fundamentals section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Zydus Wellness Ltd. was on 2023-07-21 for Rs. 5 per share. According to today’s share price, the dividend yield of Zydus Wellness Ltd. stands at 0.20. Please refer to the Corporate Actions section for further details.

Please find Corporate actions section for more details.

Please find Corporate actions section for more details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Zydus Wellness Ltd..

Close

Let's Open Free Demat Account